Table 3. Results–angiogenic expression profile of 24 human tumours.
| Patient ID | CD34 MVD per mm2 | SMA PCI (%) | CD105 MVD per mm2 | VEGF | Ki-67 (%) | Glut-1 (%) | Ang-1 | Ang-2 | PDGF | CD61 MVD per mm2 |
|---|---|---|---|---|---|---|---|---|---|---|
| 01 | 153.67 | 31.70 | 6.88 | 0 | ND | 0.5 | ND | ND | ND | ND |
| 02 | 96.33 | 66.85 | 20.64 | 1 | 0.5 | 1.0 | 3 | 1 | 0 | 47.02 |
| 03 | 182.34 | 54.58 | 64.22 | 0 | 20.0 | 0.5 | 1 | 2 | 0 | 18.35 |
| 04 | 97.48 | 85.73 | 53.90 | 2 | 15.0 | 15.0 | 2 | 3 | 2 | 19.50 |
| 05 | 127.29 | 73.69 | 57.34 | 2 | 30.0 | 10.0 | 1 | 2 | 0 | 26.38 |
| 06 | 26.38 | 47.50 | 13.76 | 0 | 1.0 | 1.0 | 3 | 3 | 0 | 11.47 |
| 07 | 157.11 | 50.99 | 11.47 | 1 | 10.0 | 1.0 | 1 | 1 | 0 | 19.50 |
| 08 | 92.89 | 24.67 | 5.73 | 1 | 15.0 | 20.0 | 1 | 1 | 0 | 9.17 |
| 09 | 137.61 | 59.03 | 10.32 | 0 | 10.0 | 1.0 | 2 | 1 | 0 | 17.20 |
| 10 | 96.33 | 41.54 | 38.99 | 2 | 50.0 | 30.0 | 0 | 2 | 1 | 43.58 |
| 11 | 151.38 | 72.51 | 59.63 | 0 | 2.0 | 0.5 | 1 | 2 | 0 | 10.32 |
| 12 | 60.78 | 55.58 | 19.50 | 2 | 40.0 | 30.0 | 0 | 1 | 0 | 6.88 |
| 13 | 83.72 | 57.14 | 10.32 | 2 | 5.0 | 0.5 | 1 | 1 | 0 | 1.15 |
| 14 | 160.55 | 20.53 | 76.83 | 2 | 10.0 | 5.0 | 1 | 2 | 0 | 29.82 |
| 15 | 150.23 | 30.60 | 30.96 | 1 | 15.0 | 25.0 | 1 | 3 | 0 | 19.50 |
| 16 | 110.09 | 77.43 | 27.52 | 0 | 15.0 | 1.0 | 2 | 1 | 2 | 11.47 |
| 17 | 123.85 | 57.90 | 29.82 | 2 | 20.0 | 5.0 | 2 | 3 | 0 | 5.73 |
| 18 | 65.37 | 66.37 | 24.08 | 3 | 60.0 | 20.0 | 1 | 3 | 0 | 16.06 |
| 19 | 128.44 | 44.58 | 16.06 | 2 | 30.0 | 10.0 | 1 | 2 | 0 | 24.08 |
| 20 | 90.60 | 80.15 | 26.38 | 2 | 30.0 | 5.0 | 2 | 2 | 0 | 6.88 |
| 21 | 79.13 | 32.63 | 36.70 | 3 | 1.0 | 60.0 | 1 | 3 | 1 | 27.52 |
| 22 | 82.57 | 79.83 | 11.47 | 2 | 40.0 | 25.0 | 2 | 2 | 0 | 9.17 |
| 23 | 142.09 | 60.85 | 3.40 | 3 | 40.0 | 2.0 | 1 | 1 | 0 | 8.52 |
| 24 | 178.90 | 53.00 | 73.39 | 2 | 25.0 | 15.0 | 3 | 3 | 1 | 12.61 |
MVD=microvessel density; ND=not done, due to lack of available tumour tissue; PCI=pericyte coverage index. For the categorical variables, 0=negative; 1=weak expression; 2=moderate expression; 3=strong expression.